Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Sandig

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Vaccine|February 14, 2018
High-cell-density cultivations to increase MVA virus productionDaniel Vázquez-Ramírez, Yvonne Genzel, Ingo Jordan, et al.
Applied Microbiology and Biotechnology|February 24, 2019
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF systemDaniel Vázquez-Ramírez, Ingo Jordan, Volker Sandig, et al.
Virus Research|June 23, 2009
Cell lines from the Egyptian fruit bat are permissive for modified vaccinia AnkaraIngo Jordan, Deborah Horn, Stefanie Oehmke, et al.
BMC Proceedings|March 1, 2012
DoE of fed-batch processes - model-based design and experimental evaluationOnur Sercinoglu, Oscar Platas Barradas, Volker Sandig, et al.
Plos One|November 6, 2019
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect"Felipe Tapia, Daniel Wohlfarth, Volker Sandig, et al.
Frontiers in Bioengineering and Biotechnology|July 28, 2020
Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion ModeJuliana Coronel, Gwendal Gränicher, Volker Sandig, et al.
Virologica Sinica|December 14, 2019
A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA)Ingo Jordan, Deborah Horn, Kristin Thiele, et al.
Vaccine|December 17, 2008
An avian cell line designed for production of highly attenuated virusesIngo Jordan, Ad Vos, Stefanie Beilfuss, et al.
Virology|September 21, 2025
A chiropteran factor of innate immunity can be recruited for rapid rescue and amplification of recombinant modified vaccinia Ankara (MVA)Aurora Elhazaz Fernandez, Sirine Abidi, Karoline Mähl, et al.
BMC Biotechnology|June 17, 2022
Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIXKhaled Trabelsi, Meriem Ben Zakour, Ingo Jordan, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Vaccine|February 14, 2018
High-cell-density cultivations to increase MVA virus productionDaniel Vázquez-Ramírez, Yvonne Genzel, Ingo Jordan, et al.
Applied Microbiology and Biotechnology|February 24, 2019
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF systemDaniel Vázquez-Ramírez, Ingo Jordan, Volker Sandig, et al.
Virus Research|June 23, 2009
Cell lines from the Egyptian fruit bat are permissive for modified vaccinia AnkaraIngo Jordan, Deborah Horn, Stefanie Oehmke, et al.
BMC Proceedings|March 1, 2012
DoE of fed-batch processes - model-based design and experimental evaluationOnur Sercinoglu, Oscar Platas Barradas, Volker Sandig, et al.
Plos One|November 6, 2019
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect"Felipe Tapia, Daniel Wohlfarth, Volker Sandig, et al.
Frontiers in Bioengineering and Biotechnology|July 28, 2020
Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion ModeJuliana Coronel, Gwendal Gränicher, Volker Sandig, et al.
Virologica Sinica|December 14, 2019
A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA)Ingo Jordan, Deborah Horn, Kristin Thiele, et al.
Vaccine|December 17, 2008
An avian cell line designed for production of highly attenuated virusesIngo Jordan, Ad Vos, Stefanie Beilfuss, et al.
Virology|September 21, 2025
A chiropteran factor of innate immunity can be recruited for rapid rescue and amplification of recombinant modified vaccinia Ankara (MVA)Aurora Elhazaz Fernandez, Sirine Abidi, Karoline Mähl, et al.
BMC Biotechnology|June 17, 2022
Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIXKhaled Trabelsi, Meriem Ben Zakour, Ingo Jordan, et al.
Pageof 7